ES8305325A1 - "procedimiento para preparar derivados de 2-oxoazetidina". - Google Patents
"procedimiento para preparar derivados de 2-oxoazetidina".Info
- Publication number
- ES8305325A1 ES8305325A1 ES513420A ES513420A ES8305325A1 ES 8305325 A1 ES8305325 A1 ES 8305325A1 ES 513420 A ES513420 A ES 513420A ES 513420 A ES513420 A ES 513420A ES 8305325 A1 ES8305325 A1 ES 8305325A1
- Authority
- ES
- Spain
- Prior art keywords
- amino group
- chem
- acylated
- production
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 title 1
- 125000003277 amino group Chemical group 0.000 abstract 4
- CDFGMYLBUSYTKQ-UHFFFAOYSA-N 2-oxoazetidine-1-sulfonic acid Chemical class OS(=O)(=O)N1CCC1=O CDFGMYLBUSYTKQ-UHFFFAOYSA-N 0.000 abstract 1
- 108090000204 Dipeptidase 1 Proteins 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 102000006635 beta-lactamase Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR DERIVADOS DE 2-OXOAZETIDINA, DE FORMULA GENERAL (I), DONDE R ES UN GRUPO AMINO ACILADO; X ES HIDROGENO O METOXI; Y R ES AZIDO, HALOGENO, UN GRUPO AMINO QUE PUEDE ESTAR ACILADO, UN GRUPO -OR O -S-S-R , DONDE R ES UN RESIDUO ORGANICO; Y N ES 0, 1 O 2, Y SUS SALES Y ESTERES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN ACILAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE X Y R TIENEN LOS SIGNIFICADOS YA INDICADOS. DE APLICACION EN LA PREPARACION DE ANTIBIOTICOS UTILIZADOS EN EL TRATAMIENTO Y PREVENCION DE INFECCIONES BACTERIANAS.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1980/000296 WO1982001872A1 (en) | 1980-12-05 | 1980-12-05 | Azetidine derivatives and process for their preparation |
| PCT/JP1981/000102 WO1982003858A1 (fr) | 1981-04-30 | 1981-04-30 | Derives d'azetidine et procede de preparation |
| PCT/JP1981/000192 WO1983000690A1 (en) | 1981-08-25 | 1981-08-25 | Azetidine derivatives and process for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES513420A0 ES513420A0 (es) | 1983-04-01 |
| ES8305325A1 true ES8305325A1 (es) | 1983-04-01 |
Family
ID=27303167
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES507716A Expired ES8301915A1 (es) | 1980-12-05 | 1981-12-04 | Procedimiento para preparar derivados de 2-oxoazetidina . |
| ES513420A Expired ES8305325A1 (es) | 1980-12-05 | 1982-06-25 | "procedimiento para preparar derivados de 2-oxoazetidina". |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES507716A Expired ES8301915A1 (es) | 1980-12-05 | 1981-12-04 | Procedimiento para preparar derivados de 2-oxoazetidina . |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4822790A (es) |
| EP (1) | EP0053815B1 (es) |
| JP (1) | JPS57131759A (es) |
| KR (1) | KR880001564B1 (es) |
| AT (3) | AT379800B (es) |
| AU (1) | AU551463B2 (es) |
| CH (1) | CH656122A5 (es) |
| DE (2) | DE3148020A1 (es) |
| DK (1) | DK534381A (es) |
| ES (2) | ES8301915A1 (es) |
| FI (1) | FI79528C (es) |
| FR (1) | FR2495612A1 (es) |
| GB (1) | GB2091723B (es) |
| HU (1) | HU189545B (es) |
| IE (1) | IE53451B1 (es) |
| IL (1) | IL64314A (es) |
| IT (1) | IT1146726B (es) |
| LU (1) | LU83820A1 (es) |
| MX (1) | MX7096E (es) |
| NL (1) | NL8105468A (es) |
| NO (1) | NO160297C (es) |
| NZ (1) | NZ199168A (es) |
| PT (1) | PT74087B (es) |
| SE (1) | SE8107273L (es) |
| SU (2) | SU1662348A3 (es) |
| WO (1) | WO1982002042A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU557649B2 (en) * | 1981-03-30 | 1987-01-08 | E.R. Squibb & Sons, Inc. | 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts |
| US4734496A (en) * | 1981-05-29 | 1988-03-29 | E. R. Squibb & Sons, Inc. | 4-amino derivatives of 2-oxo-1-azetidinesulfonic acid salts |
| JPS588060A (ja) * | 1981-06-29 | 1983-01-18 | イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド | アリ−ルチオアゼチジノンスルホン酸塩類 |
| FR2509726B1 (es) * | 1981-07-16 | 1984-04-27 | Squibb & Sons Inc | |
| EP0076758B1 (en) * | 1981-10-05 | 1987-01-07 | E.R. Squibb & Sons, Inc. | 4-ether derivatives of 2-azetidinone-1-sulfonic acids |
| AU564150B2 (en) * | 1982-04-30 | 1987-08-06 | Takeda Chemical Industries Ltd. | 1-sulfo-2-azetidinone derivatives |
| JPS58210060A (ja) * | 1982-05-31 | 1983-12-07 | Takeda Chem Ind Ltd | ２−オキソアゼチジン誘導体、その製造法および用途 |
| JPS5916888A (ja) * | 1982-07-20 | 1984-01-28 | Takeda Chem Ind Ltd | １−スルホ−２−アゼチジノン誘導体およびその製造法 |
| US4681937A (en) * | 1982-09-27 | 1987-07-21 | E. R. Squibb & Sons, Inc. | 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters |
| JPS59101485A (ja) * | 1982-11-29 | 1984-06-12 | Otsuka Chem Co Ltd | アセチジノン誘導体 |
| DE3342929A1 (de) * | 1983-11-26 | 1985-06-05 | Bayer Ag, 5090 Leverkusen | Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel |
| US4883869A (en) * | 1984-12-20 | 1989-11-28 | The Upjohn Company | Novel beta-lactams containing amino acid substituents |
| US5006650A (en) * | 1987-02-11 | 1991-04-09 | The Upjohn Company | Novel N-1 substituted beta-lactams as antibiotics |
| KR890700586A (ko) * | 1987-02-27 | 1989-04-25 | 로버어트 에이 아마테이지 | 피리돈 카르복실산 또는 산유도체를 함유하는 항균제 베타-락탐 |
| CA1317298C (en) * | 1987-03-03 | 1993-05-04 | Upjohn Company (The) | Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
| US5015737A (en) * | 1987-07-22 | 1991-05-14 | The Upjohn Company | Therapeutically useful beta-lactams |
| CA2266639A1 (en) * | 1996-09-23 | 1998-03-26 | Rajeshwar Singh | 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6046955B2 (ja) * | 1977-12-30 | 1985-10-18 | 武田薬品工業株式会社 | 抗生物質ｇ−６３０２ |
| JPS5549394A (en) * | 1978-10-03 | 1980-04-09 | Takeda Chem Ind Ltd | Antibiotic substance sb-72310 |
| US4260627A (en) * | 1978-10-24 | 1981-04-07 | Merck & Co., Inc. | 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids |
| CA1242188A (en) * | 1979-06-08 | 1988-09-20 | Takeda Pharmaceutical Company Limited | 3-methoxy-2-oxoazetidine derivatives and their production |
| EP0021678B1 (en) * | 1979-06-08 | 1984-11-07 | Takeda Chemical Industries, Ltd. | 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof |
| NZ205240A (en) * | 1980-02-07 | 1984-07-31 | Squibb & Sons Inc | Sulphonamide derivatives,being starting materials for producing beta-lactams |
| AU557649B2 (en) * | 1981-03-30 | 1987-01-08 | E.R. Squibb & Sons, Inc. | 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts |
| JPS588060A (ja) * | 1981-06-29 | 1983-01-18 | イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド | アリ−ルチオアゼチジノンスルホン酸塩類 |
| FR2509726B1 (es) * | 1981-07-16 | 1984-04-27 | Squibb & Sons Inc | |
| FR2515182B1 (fr) * | 1981-10-23 | 1986-05-09 | Roussel Uclaf | Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation |
-
1980
- 1980-12-05 MX MX819801U patent/MX7096E/es unknown
-
1981
- 1981-11-19 IL IL64314A patent/IL64314A/xx unknown
- 1981-11-26 HU HU813576A patent/HU189545B/hu not_active IP Right Cessation
- 1981-12-02 NO NO814113A patent/NO160297C/no unknown
- 1981-12-02 DK DK534381A patent/DK534381A/da not_active Application Discontinuation
- 1981-12-02 FI FI813851A patent/FI79528C/fi not_active IP Right Cessation
- 1981-12-03 US US06/326,939 patent/US4822790A/en not_active Expired - Fee Related
- 1981-12-03 SU SU813364650A patent/SU1662348A3/ru active
- 1981-12-04 SE SE8107273A patent/SE8107273L/xx unknown
- 1981-12-04 IE IE2859/81A patent/IE53451B1/en unknown
- 1981-12-04 AT AT0520781A patent/AT379800B/de not_active IP Right Cessation
- 1981-12-04 JP JP56196078A patent/JPS57131759A/ja active Pending
- 1981-12-04 EP EP81110154A patent/EP0053815B1/en not_active Expired
- 1981-12-04 AT AT81110154T patent/ATE13178T1/de not_active IP Right Cessation
- 1981-12-04 FR FR8122774A patent/FR2495612A1/fr active Granted
- 1981-12-04 GB GB8136617A patent/GB2091723B/en not_active Expired
- 1981-12-04 IT IT68585/81A patent/IT1146726B/it active
- 1981-12-04 PT PT74087A patent/PT74087B/pt unknown
- 1981-12-04 DE DE19813148020 patent/DE3148020A1/de not_active Withdrawn
- 1981-12-04 ES ES507716A patent/ES8301915A1/es not_active Expired
- 1981-12-04 LU LU83820A patent/LU83820A1/xx unknown
- 1981-12-04 NZ NZ199168A patent/NZ199168A/en unknown
- 1981-12-04 NL NL8105468A patent/NL8105468A/nl not_active Application Discontinuation
- 1981-12-04 DE DE8181110154T patent/DE3170437D1/de not_active Expired
- 1981-12-04 CH CH7786/81A patent/CH656122A5/de not_active IP Right Cessation
- 1981-12-05 WO PCT/JP1981/000368 patent/WO1982002042A1/ja unknown
- 1981-12-05 KR KR1019810004759A patent/KR880001564B1/ko active
- 1981-12-07 AU AU78313/81A patent/AU551463B2/en not_active Ceased
-
1982
- 1982-06-25 ES ES513420A patent/ES8305325A1/es not_active Expired
-
1983
- 1983-02-02 SU SU833547568A patent/SU1531852A3/ru active
-
1984
- 1984-05-23 AT AT0170384A patent/AT380471B/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8305325A1 (es) | "procedimiento para preparar derivados de 2-oxoazetidina". | |
| TW197435B (es) | ||
| MY108891A (en) | Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor | |
| TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
| YU54189A (en) | Process for obtaining cephem derivatives and midproducts for the same | |
| ATE146476T1 (de) | Cephalosporinverbindungen und verfahren zu ihrer herstellung | |
| ES8403866A1 (es) | Un metodo de producir un derivado de 4-ciano-2-azetidinona. | |
| FI895139A0 (fi) | Pyrrolidinderivat. | |
| ES8303327A1 (es) | Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina . |